Gary L. Obrien

Background

About Gary L. Obrien

Dr. Gary O’Brien has more than 10 years of international experience in the healthcare and biopharmaceutical industries across Ireland, the United Kingdom, Western Europe, Australia and the APAC region. Being the first person in Ireland to receive an Irish Research Council PhD scholarship in the field of Clinical Pharmacy, he holds a PhD from University College Cork, Ireland in Pharmacoeconomics and Health Policy, a Master of Pharmacy from the Royal College of Surgeons, Ireland, a Postgraduate Certificate in Innovation, Commercialisation and Entrepreneurship from University College Cork, Ireland, and a Bachelors of Pharmacy from University College Cork, Ireland. He has also completed additional Health Economics training at the University of York, England and at Oxford University, England. His professional portfolio encompasses policy design and evaluation, cost-effectiveness analysis, drug reimbursement, national payment systems, and clinical trials. Early in his career, Gary began as a Community and Clinical Trials Pharmacist working in the Irish and European Healthcare landscapes before returning to academia. During the time spent in academia completing his PhD in Pharmacoeconomics and Health Policy, Gary worked as Clinical Pharmacy lecturer publishing over 30 publications. After this period, Gary worked in various pharmaceutical industry roles such as Clinical Trial Associate for Eli Lilly, Health Economist for GSK, Market Access and Government Affairs Manager for AbbVie, Senior Health Economics and Market Access Manager for Biointelect. He has broad exposure across the healthcare sectors, collaborating with Government bodies, industry, patient advocacy groups and other non-profit organisations. In recent years, he has achieved numerous pharmaceutical product reimbursements in the Oncology, Infectious Disease, Rare Disease, and Neuroscience spaces. Gary has lead numerous projects with biopharmaceutical companies, Government agencies, and patient organisations. His expertise have contributed to the development of actionable strategies and support in areas such as reimbursement submissions, policy white papers, stakeholder engagement, internal workshops and reports.